Use of Zoledronic Acid in the Treatment of Paget's Disease
MetadataShow full item record
CitationSeton, Margaret, and Stephen M. Krane. 2007. Use of zoledronic acid in the treatment of Paget's disease. Therapeutics and Clinical Risk Management 3(5): 913-918.
AbstractThis review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in this disorder. Risk of oversuppression of bone by the more potent bisphosphonates and their association with avascular necrosis of the jaw are noted.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:5310895
- HMS Scholarly Articles